MERCURY PUBLIC AFFAIRS, LLC for EMERGENT BIOSOLUTIONS INC
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R 2366 S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRYAN LANZA | — |
| TOBY MOFFETT New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.